Raymond James & Associates’s PLDT PHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-10,934
Closed -$474K 3083
2016
Q1
$474K Buy
10,934
+460
+4% +$19.6K ﹤0.01% 2073
2015
Q4
$448K Buy
+10,474
New +$472K ﹤0.01% 2042
2015
Q2
Sell
-87,512
Closed -$5.47M 2429
2015
Q1
$5.47M Sell
87,512
-45,255
-34% -$3.04M 0.02% 703
2014
Q4
$8.4M Buy
132,767
+7,207
+6% +$478K 0.04% 471
2014
Q3
$8.66M Buy
125,560
+18,352
+17% +$1.33M 0.05% 409
2014
Q2
$7.22M Buy
107,208
+10,785
+11% +$700K 0.04% 469
2014
Q1
$5.88M Buy
96,423
+10,042
+12% +$602K 0.04% 508
2013
Q4
$5.19M Buy
86,381
+24,188
+39% +$1.54M 0.04% 520
2013
Q3
$4.22M Buy
62,193
+4,912
+9% +$332K 0.04% 539
2013
Q2
$3.89M Buy
+57,281
New +$4.08M 0.04% 521

Other funds holding PHI

Raymond James & Associates's PHI Position: Q2 2016 in Review

Raymond James & Associates sold out of PLDT (PHI) in Q2 2016, closing a stake of 10,934 shares — an estimated $474K sold.

Raymond James & Associates first reported a position in PHI in Q2 2013 and held it in 10 quarters. The position peaked at $8.66M in Q3 2014. 78 funds tracked by Wall St. Rank hold PHI as of Q2 2016.

  • Raymond James & Associates reported no remaining PLDT position as of Q2 2016 after selling out during the quarter.
  • Raymond James & Associates sold 10,934 PLDT shares in Q2 2016, an estimated $474K.
  • Raymond James & Associates first reported a position in PLDT in Q2 2013 and held it in 10 quarters.
  • Raymond James & Associates's PLDT position peaked at $8.66M in Q3 2014.
  • 78 funds tracked by Wall St. Rank held PLDT as of Q2 2016.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.